VRXA · Veraxa Biotech Holding AG
$1.84
-0.03 (-1.60%)
At close · Aug 17
Market Cap
$271.62M
Shares
145.25M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.87
Open$1.91
Day$1.83–1.93
52W close$1.73–24.79
Avg vol 30d545K
Short int400K · 0.3% float · 1.2d
Short vol6%
DataSep 2024–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−80%
below
Price vs 50-day avg
−61%
below
RSI (14)
38
neutral
MACD trend
Positive
52-week position
1%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−14%
trailing
6-month return
−82%
trailing
YTD return
−82%
this year
Relative strength
−96%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
+27 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.28% of float · ▲ +66.1% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
27 holders — 13F breadth
Squeeze score
40
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
130%
annualized · 1-yr
Max drawdown
−93%
past year
ATR
22.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−80%
Bearish
Price vs 50-day avg
−61%
Bearish
RSI (14)
38
Neutral
MACD trend
Positive
Bullish
52-week position
1%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $5 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
+27 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.28% of float · ▲ +66.1% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
27 holders — 13F breadth
Price context
position in its 52-week range
Range low $2
Now $2 · 1%
Range high $25
vs 200-day avg -80%
vs 50-day avg -61%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VRXA
this stock
Veraxa Biotech Holding AG
|
$271.62M | -82.5% | — | — | 0.3% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
27
- % held
- 5.8%
- Net QoQ
- +8.4M sh
- Top holder
- CSS LLC/IL
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VRXA | -6.0% | -14.2% | -82.5% | +6.3% | -82.5% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -6.4% | -18.7% | -96.2% | +2.3% | -96.3% |
Key facts
CIK
2079109
CUSIP
H9130A103
13F (30d)
30 filings
30 filers
Visit website
Investor relations